Breaking News Instant updates and real-time market news.

JPM

JPMorgan

$66.03

-0.08 (-0.12%)

, WBA

Walgreens Boots Alliance

$80.38

-0.24 (-0.30%)

05:43
10/04/16
10/04
05:43
10/04/16
05:43

JPMorgan set to remove Chase ATMs from Walgreens stores, Reuters reports

JPMorgan (JPM) is set to remove Chase ATMs from Walgreens (WBA) and Duane Reade drug stores a decade after installing the machines, Reuters reports. In April, JPMorgan agreed to sell 2,586 cash machines, mainly in Walgreens and Duane Reade, to Cardtronics (CATM) for an undisclosed sum, the report notes. The deal includes ATMs in Walgreens drug stores in nine states. Reference Link

JPM

JPMorgan

$66.03

-0.08 (-0.12%)

WBA

Walgreens Boots Alliance

$80.38

-0.24 (-0.30%)

CATM

Cardtronics

$48.14

3.54 (7.94%)

  • 14

    Oct

  • 20

    Oct

  • 21

    Oct

  • 23

    Oct

  • 06

    Nov

  • 16

    Nov

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

JPM JPMorgan
$66.03

-0.08 (-0.12%)

09/09/16
09/09/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JPMorgan (JPM) downgraded to Neutral from Outperform at Macquarie with analyst David Konrad citing valuation. 2. CarMax (KMX) downgraded to Neutral from Buy at Buckingham with analyst Glenn Chin citing valuation. 3. Eaton (ETN) and Ingersoll-Rand (IR) downgraded to Sector Weight from Overweight at KeyBanc with analyst Jeffrey Hammond citing his more cautious outlook for nonresidential construction. 4. Estee Lauder (EL) downgraded to Hold from Buy at Argus with analyst John Staszak saying it will be difficult for the company to achieve further market share gains, given increased competition, slowing growth in the premium beauty products space, and a "challenging" macro environment. 5. SAIC (SAIC) downgraded to Market Perform from Outperform at Cowen and to Hold from Buy at Drexel Hamilton. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/09/16
MACQ
09/09/16
DOWNGRADE
Target $70
MACQ
Neutral
JPMorgan downgraded to Neutral from Outperform at Macquarie
Macquarie analyst David Konrad downgraded JPMorgan to Neutral due to valuation and maintained its $70 price target. The analyst said the interest rate environment is expected to remain challenging and cost-save expectations are largely built into expectations. Further, Konrad believes "meaningfully improved ROE may be difficult with higher-than-peer required capital buffers."
09/28/16
DBAB
09/28/16
UPGRADE
Target $11.5
DBAB
Buy
Huntington Bancshares upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Matt O'Connor upgraded Huntington Bancshares to Buy saying the 15% pullback in the shares since the FirstMerit (FMER) deal was announced is overdone. The analyst views industry-wide concerns surrounding consumer indirect auto lending as overblown and he raised his price target for Huntington shares to $11.50 from $10.50. Going into the Q3 results for U.S. banks, O'Connor likes JPMorgan (JPM) and Wells Fargo (WFC) and is cautious on Fifth Third (FITB).
08/16/16
08/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hain Celestial (HAIN) downgraded to Equal Weight from Overweight at Barclays, to Neutral from Buy at SunTrust, to Underweight from Neutral at Piper Jaffray, and to Underweight from Neutral at Atlantic Equities. 2. JPMorgan (JPM), SunTrust (STI), and Regions Financial (RF) downgraded to Market Perform from Outperform at Bernstein. 3. Performance Sports Group (PSG) downgraded to Neutral from Outperform at Wedbush with analyst James Hardiman saying the delay in the filing of the company's 10-K could cause it to default. 4. Ocean Rig UDW (ORIG) downgraded to Hold from Buy at Deutsche Bank with analyst Mike Urban saying the company's restructuring is likely unfavorable for existing equity holders. 5. Alarm.com (ALRM) downgraded to Market Perform from Outperform at Raymond James with the firm citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
WBA Walgreens Boots Alliance
$80.38

-0.24 (-0.30%)

07/07/16
BARD
07/07/16
NO CHANGE
Target $95
BARD
Outperform
Walgreens Boots Alliance estimates, price target lowered at Baird
Baird analyst Eric Coldwell lowered his price target for Walgreens Boots Alliance (WBA) to $95 from $98 and cut his fiscal year 2017 outlook modestly following the company's mixed earnings report and due to incremental currency headwind. Nonetheless, he believes the damage is "largely done" and reiterates an Outperform rating on the shares, while waiting for the Rite Aid (RAD) deal and further efficiency improvements.
07/18/16
MZHO
07/18/16
NO CHANGE
MZHO
Valeant likely to lower 2016 guidance again, says Mizuho
Mizuho expects Valeant to report slightly lower than expected Q2 EPS. The firm says that the company's guidance implies that its operating spending will drop in 2H16. Mizuho thinks that this outlook is unrealistic. The firm adds that the company's belief that its revenue will be boosted by seasonality and improved economics from the Walgreens (WBA) deal could also be unrealistic. The firm reiterates an $11 price target and Unerperform ratingon Valeant.
07/19/16
LEER
07/19/16
NO CHANGE
Target $95
LEER
Outperform
Leerink remains positive on Walgreens Boots Alliance long-term
Leerink analyst David Larsen remains positive on Walgreens Boots Alliance (WBA) in the long-term, despite reducing his forward revenue and earnings estimates due mainly to trends in FX. Larsen still believes that the Rite Aid (RAD) deal will close in the second half of 2016, and expects shares of Walgreens Boots Alliance to rally once that happens. The analyst reiterates an Outperform rating and $95 price target on Walgreens Boots Alliance's shares.
09/01/16
FBCO
09/01/16
NO CHANGE
FBCO
Walgreens Boots Alliance added to Focus List at Credit Suisse
Credit Suisse analyst Robert Willoughby said Walgreens Boots Alliance (WBA) closing of the Rite Aid (RAD) acquisition in 2H 2016 will bring meaningful revenue growth, cash flow, and cost cutting opportunities to drive Walgreens shares higher. The analyst sees limited downside given new and potentially more preferred pharmacy network agreements with leading PBMs, capital deployment, and the early AmerisourceBergan warrant exercise. Willoughby reiterates his Outperform rating and $95 price target on Walgreens shares and the investment policy committee added it to the Credit Suisse Focus List.
CATM Cardtronics
$48.14

3.54 (7.94%)

08/19/16
JPMS
08/19/16
DOWNGRADE
Target $50
JPMS
Neutral
Cardtronics downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Reginald Smith downgraded Cardtronics to Neutral citing valuation with the stock up 38% year-to-date. The analyst sees limited upside from current share levels and upped his price target for the shares to $50 from $45.
07/29/16
BRRR
07/29/16
DOWNGRADE
BRRR
Market Perform
Cardtronics downgraded to Market Perform from Outperform at Barrington
Barrington analyst Gary Prestopino downgraded Cardtronics to Market Perform citing valuation with the shares at the top end of his $40-$45 price target range. The analyst notes the company's Q2 results were better than expected.
09/22/16
FLTL
09/22/16
INITIATION
Target $48
FLTL
Buy
Cardtronics initiated with a Buy at Feltl
Feltl initiated Cardtronics with a Buy and a $48 price target.
08/19/16
08/19/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Buffalo Wild Wings (BWLD) downgraded to Underperform from Neutral at Longbow. 2. AK Steel (AKS) downgraded to Underweight from Sector Weight at KeyBanc with analyst Philip Gibbs saying he's incrementally cautious on U.S. carbon sheet market outlook due to slowing demand and fourth quarter supply risks. 3. SunEdison Semiconductor (SEMI) downgraded to Hold from Buy at Deutsche Bank and to Market Perform at Wells Fargo. 4. Juniper Pharma (JNP) downgraded to Market Perform from Outperform at Northland and to Neutral from Buy at H.C. Wainwright. 5. Cardtronics (CATM) downgraded to Neutral from Overweight at JPMorgan with analyst Reginald Smith citing valuation with the stock up 38% year-to-date. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.